Gerostate Alpha
Developing novel therapeutics for aging and chronic disease
Y CombinatorSummer 2018InactiveHealthcareTherapeuticsBiotechTherapeutics
What they do
Problem
Aging and chronic diseases lack effective treatments that address underlying biological mechanisms.
Solution
It develops novel therapeutics targeting aging biology to prevent or treat chronic disease.
Who it's for
Pharmaceutical and biotechnology companies and healthcare systems seeking new therapeutics for aging-related chronic diseases.
Founders
Gordon J Lithgow
Founder
Mark Lucanic
Founder
Simon Melov
Founder
Company timeline
- YC batchSummer 2018
- StatusInactive
- Team size6 people
- LocationNovato, CA, USA
Similar startups
Scribe Therapeutics
“I watched a video by Bill Gates and Steve Wozniak from the beginning…
Quince Therapeutics
Quince TherapeuticsQuince Therapeutics (fka Cortexyme) is a late-stag…
Adventris Pharmaceuticals
Adventris makes cancer vaccines
Tradewind BioScience
Tradewind translates scientific insight into innovative ways of…
Ansa Biotechnologies
Next-generation DNA synthesis using enzymes
Kernal Biologics
Kernal is creating mRNA 2.0 therapies that work in specific cells